MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|
MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|
MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|
MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|
MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|
MI0000749
|
MIPF0000005
|
GGGCAGUCUUUGCUACUGUAAACAUCCUUGACUGGAAGCUGUAAGGUGUUCAGAGGAGCUUUCAGUCGGAUGUUUACAGCGGCAGGCUGCCA
|
MIMAT0000692
hsa-miR-30e-5p
|
UGUAAACAUCCUUGACUGGAAG
|
This sequence is the predicted human homologue of mouse miR-30e [1,2,4].Mature products from both arms of the precursor (hsa-miR-30e-5p andhsa-miR-30e-3p) were later independently verified in human myelocyticleukemia (HL-60) cells . Landgraf et al. later showed that the 5'product is the predominant one . The mature sequence shown hererepresents the most commonly cloned form from large-scale cloning studies.
|